Mesoridazine: Difference between revisions

Jump to navigation Jump to search
No edit summary
No edit summary
 
Line 57: Line 57:
}}
}}
__NOTOC__
__NOTOC__
{{SI}}
{{SI}}
{{CMG}}
{{CMG}}
==Overview==
==Overview==
'''Mesoridazine''' ('''Serentil''') is a [[piperidine]] [[neuroleptic]] drug belonging to the class of drugs called [[phenothiazine]]s, used in the treatment of [[schizophrenia]]. It is a metabolite of [[thioridazine]]. The drug's name is derived from the '''me'''thyl'''s'''ulf'''o'''xy and pipe'''rid'''ine functional groups in its chemical structure.
'''Mesoridazine''' ('''Serentil''') is a [[piperidine]] [[neuroleptic]] drug belonging to the class of drugs called [[phenothiazine]]s, used in the treatment of [[schizophrenia]]. It is a metabolite of [[thioridazine]]. The drug's name is derived from the '''me'''thyl'''s'''ulf'''o'''xy and pipe'''rid'''ine functional groups in its chemical structure.
Line 76: Line 73:
Mesoridazine (10-[2-(1-methyl-2-piperidyl)ethyl]-2-(methylsufinyl)phenothiazine) is synthesized by an analogous scheme to that seen already for [[thioridazine]].
Mesoridazine (10-[2-(1-methyl-2-piperidyl)ethyl]-2-(methylsufinyl)phenothiazine) is synthesized by an analogous scheme to that seen already for [[thioridazine]].


[[File:Mesoridazine synthesis.png|700px|thumb|center|Mesoridazine synthesis:<ref>{{Cite doi|10.1002/hlca.19580410420}}</ref> J. Renz, G. Schwarb, {{US Patent|3084161}} (1960).]]
[[File:Mesoridazine synthesis.png|400px|none|left]]


However, it is also synthesized by alkylating the acidic form of 2-methylthiophenothiazine -methylsulfonylphenothiazine- using 2-(2-chloroethyl)-1-methylpiperidine. 2-methylthiophenothiazine is initially acylated at the nitrogen atom using [[acetic anhydride]], giving 10-acetyl-2-methylthiophenothiazine. The resulting acetyl derivative is further oxidized by [[hydrogen peroxide]] into 10-acetyl-2-methylsulfonylpenothiazine. Deacylation of this product in [[potassium carbonate]] methanol solution gives 2-methylsulfanylphenothiazine, which is alkylated by 2-(2-chlorethyl)-1-methylpiperidine in the presence of [[sodamide]], affording the desired mesoridazine.
However, it is also synthesized by alkylating the acidic form of 2-methylthiophenothiazine -methylsulfonylphenothiazine- using 2-(2-chloroethyl)-1-methylpiperidine. 2-methylthiophenothiazine is initially acylated at the nitrogen atom using [[acetic anhydride]], giving 10-acetyl-2-methylthiophenothiazine. The resulting acetyl derivative is further oxidized by [[hydrogen peroxide]] into 10-acetyl-2-methylsulfonylpenothiazine. Deacylation of this product in [[potassium carbonate]] methanol solution gives 2-methylsulfanylphenothiazine, which is alkylated by 2-(2-chlorethyl)-1-methylpiperidine in the presence of [[sodamide]], affording the desired mesoridazine.
Line 84: Line 81:


{{Antipsychotics}}
{{Antipsychotics}}
{{Adrenergics}}
{{Cholinergics}}
{{Dopaminergics}}
{{Histaminergics}}
{{Serotonergics}}
{{Tricyclics}}


[[Category:Phenothiazines]]
[[Category:Phenothiazines]]

Latest revision as of 15:12, 13 April 2015

Mesoridazine
Clinical data
Trade namesSerentil
AHFS/Drugs.comMicromedex Detailed Consumer Information
MedlinePlusa682306
Pregnancy
category
  • US: C (Risk not ruled out)
Routes of
administration
oral, intravenous
ATC code
Legal status
Legal status
  • In general: ℞ (Prescription only)
Pharmacokinetic data
Protein binding4%
MetabolismHepatic/Renal
Elimination half-life24 to 48 hours
ExcretionBiliary and renal
Identifiers
CAS Number
PubChem CID
DrugBank
ChemSpider
UNII
KEGG
ChEBI
ChEMBL
E number{{#property:P628}}
ECHA InfoCard{{#property:P2566}}Lua error in Module:EditAtWikidata at line 36: attempt to index field 'wikibase' (a nil value).
Chemical and physical data
FormulaC21H26N2OS2
Molar mass386.576 g/mol
3D model (JSmol)
Melting point130 °C (266 °F)
Solubility in waterinsoluble mg/mL (20 °C)
  (verify)

WikiDoc Resources for Mesoridazine

Articles

Most recent articles on Mesoridazine

Most cited articles on Mesoridazine

Review articles on Mesoridazine

Articles on Mesoridazine in N Eng J Med, Lancet, BMJ

Media

Powerpoint slides on Mesoridazine

Images of Mesoridazine

Photos of Mesoridazine

Podcasts & MP3s on Mesoridazine

Videos on Mesoridazine

Evidence Based Medicine

Cochrane Collaboration on Mesoridazine

Bandolier on Mesoridazine

TRIP on Mesoridazine

Clinical Trials

Ongoing Trials on Mesoridazine at Clinical Trials.gov

Trial results on Mesoridazine

Clinical Trials on Mesoridazine at Google

Guidelines / Policies / Govt

US National Guidelines Clearinghouse on Mesoridazine

NICE Guidance on Mesoridazine

NHS PRODIGY Guidance

FDA on Mesoridazine

CDC on Mesoridazine

Books

Books on Mesoridazine

News

Mesoridazine in the news

Be alerted to news on Mesoridazine

News trends on Mesoridazine

Commentary

Blogs on Mesoridazine

Definitions

Definitions of Mesoridazine

Patient Resources / Community

Patient resources on Mesoridazine

Discussion groups on Mesoridazine

Patient Handouts on Mesoridazine

Directions to Hospitals Treating Mesoridazine

Risk calculators and risk factors for Mesoridazine

Healthcare Provider Resources

Symptoms of Mesoridazine

Causes & Risk Factors for Mesoridazine

Diagnostic studies for Mesoridazine

Treatment of Mesoridazine

Continuing Medical Education (CME)

CME Programs on Mesoridazine

International

Mesoridazine en Espanol

Mesoridazine en Francais

Business

Mesoridazine in the Marketplace

Patents on Mesoridazine

Experimental / Informatics

List of terms related to Mesoridazine

Editor-In-Chief: C. Michael Gibson, M.S., M.D. [2]

Overview

Mesoridazine (Serentil) is a piperidine neuroleptic drug belonging to the class of drugs called phenothiazines, used in the treatment of schizophrenia. It is a metabolite of thioridazine. The drug's name is derived from the methylsulfoxy and piperidine functional groups in its chemical structure.

It has central antiadrenergic, antidopaminergic, antiserotonergic and weak muscarinic anticholinergic effects.

Serious side effects include akathisia, tardive dyskinesia and the potentially fatal neuroleptic malignant syndrome.

Mesoridazine was withdrawn from the United States market in 2004 due to dangerous side effects, namely irregular heart beat and QT-prolongation of the electrocardiogram.[1]

It currently appears to be unavailable worldwide.

Chemistry

Mesoridazine (10-[2-(1-methyl-2-piperidyl)ethyl]-2-(methylsufinyl)phenothiazine) is synthesized by an analogous scheme to that seen already for thioridazine.

However, it is also synthesized by alkylating the acidic form of 2-methylthiophenothiazine -methylsulfonylphenothiazine- using 2-(2-chloroethyl)-1-methylpiperidine. 2-methylthiophenothiazine is initially acylated at the nitrogen atom using acetic anhydride, giving 10-acetyl-2-methylthiophenothiazine. The resulting acetyl derivative is further oxidized by hydrogen peroxide into 10-acetyl-2-methylsulfonylpenothiazine. Deacylation of this product in potassium carbonate methanol solution gives 2-methylsulfanylphenothiazine, which is alkylated by 2-(2-chlorethyl)-1-methylpiperidine in the presence of sodamide, affording the desired mesoridazine.

References